NCT01757431
- Conditions
- Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +15 more
- Locations
-
- Nagano Red Cross Hospital Nagano, Japan
- Tokyo Medical and Dental University Hospital Tokyo, Japan
Clinical trial condition
Hemolytic-Uremic Syndrome
Explore clinical trials studying Hemolytic-Uremic Syndrome. Study availability and eligibility vary by location and protocol.
30 public trials
10 recruiting studies
Hemolytic-Uremic Syndrome trial results
Completed
Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-Resistant aHUS
NCT00844545
- Conditions
- Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +14 more
- Locations
-
- Atlanta, Georgia, United States
- Fort Wayne, Indiana, United States
- New York, United States
- New York, United States
Completed
Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Sensitive aHUS
NCT00844428
- Conditions
- Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +14 more
- Locations
-
- Toronto, Canada
- Bois-Guillaume, France
- Bordeaux, France
- Lyon, France
NCT00838513
- Conditions
- Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +14 more
- Locations
-
- Toronto, Canada
- Bois-Guillaume, France
- Bordeaux, France
- Lyon, France
Completed
Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Resistant aHUS
NCT00844844
- Conditions
- Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +14 more
- Locations
-
- Atlanta, Georgia, United States
- Fort Wayne, Indiana, United States
- New York, United States
- New York, United States
NCT01193348
- Conditions
- Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +15 more
- Locations
-
- Atlanta, Georgia, United States
- Hackensack, New Jersey, United States
- Corpus Christi, Texas, United States
- Spokane, Washington, United States
NCT01755429
- Conditions
- Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +15 more
- Locations
-
- Shinshu University School of Medicine Matsumoto, Japan
- Tokyo Medical and Dental University Tokyo, Japan
Active, Not Recruiting
A Prospective, Non-interventional, Observational Study of Presentation, Treatment Patterns and Outcomes in Atypical Hemolytic Uremic Syndrome Patients
NCT06099236
- Conditions
- Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +15 more
- Locations
-
- Research Site Beijing, Beijing Municipality, China
- Research Site Chongqing, Sichuan, China
- Research Site Anhui, China
- Research Site Beijing, China
Active, Not Recruiting
A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
NCT04861259
- Conditions
- Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +14 more
- Locations
-
- Univ of CA San Francisco San Francisco, California, United States
- Children's Hospital Colorado Aurora, Colorado, United States
- Emory Children's Center Atlanta, Georgia, United States
- Washington University St Louis, Missouri, United States
Active, Not Recruiting
A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Pediatric Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
NCT04958265
- Conditions
- Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +14 more
- Locations
-
- Children's Hospital Colorado Aurora, Colorado, United States
- University of Nebraska Omaha, Nebraska, United States
- Hackensack University Medical Center Hackensack, New Jersey, United States
- UZ Gent Ghent, Belgium